The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

AGL ANGLE PLC ORD 10P




 Page 1 of 2

| 1 | 2 | Next

Time/Date Code Headline Source Impact
07:00 17-Oct-2017 AGL ANGLE: 7th Peer Reviewed Publication On Parsortix RNS -0.84% Down
07:00 12-Oct-2017 AGL Proposed further subscription for 2.8 million RNS +1.98% Up
07:02 09-Oct-2017 AGL CTCs harvested with Parsortix grown in laboratory RNS +13.26% Up
07:01 09-Oct-2017 AGL Potential new analytical protocol using Parsortix RNS +13.26% Up
07:00 09-Oct-2017 AGL Parsortix Showcased at CTC Conference RNS +13.26% Up
11:46 05-Oct-2017 AGL Results of Fundraising RNS +12.34% Up
07:00 05-Oct-2017 AGL Acquisition and Fundraising RNS +12.34% Up
17:36 13-Sep-2017 AGL Holding(s) in Company RNS +8.57% Up
07:00 13-Sep-2017 AGL Exclusive worldwide option over megakaryocyte IP RNS +8.57% Up
07:00 11-Sep-2017 AGL Co-Marketing Partnership with QIAGEN RNS +3.68% Up
07:00 05-Sep-2017 AGL Change of Adviser RNS -8.68% Down
07:00 04-Sep-2017 AGL New Research with Parsortix RNS -8.24% Down
07:00 27-Jul-2017 AGL Preliminary Results RNS -13.26% Down
13:00 20-Jul-2017 AGL Preclinical Study Presented At Tumor Boston Summit RNS -7.40% Down
10:05 06-Jul-2017 AGL Notice of Results RNS -13.87% Down
07:00 04-Jul-2017 AGL Successful Headline Data in Ovarian Cancer Studies RNS -9.88% Down
07:00 15-Jun-2017 AGL Parsortix breakthrough in prostate cancer RNS +15.87% Up
07:00 05-Jun-2017 AGL Success with Parsortix in Colorectal Cancer RNS +6.10% Up
07:00 03-May-2017 AGL Business Update RNS -3.94% Down
07:00 04-Apr-2017 AGL Holding(s) in Company RNS +5.34% Up

 Page 1 of 2

| 1 | 2 | Next



Price changes are calculated on the basis of the following formula: [ avg(x) - avg(y)] / avg(y) where:
x = instrument's 7 closing prices after the news has been released
y = instrument's latest 7 closing prices before the news was released, including the day of the release of the news

Please note that the news releases are only one of the multiple factors that could have had an impact on the change in the security’s price over the time period analysed by the News Analysis tool. Where data are insufficient the graph does not show any price change and the table below the graph displays a blank “ - “ next to the line indicating the RNS issue.




Market

Company Information
Updated Monthly
Company address 3 Frederick Sanger Road, The Surrey Research Park, Guildford, GU2 7YG, United Kingdom
Company website http://www.angleplc.com
Market cap(in millions)* £ 31.05
Listing/Admission to trading 17 Mar 2004
Trading service SEAQ
Market AIM
Listing category -
*The market capitalisation of companies reflects the London listed element only. These figures are approximate and are updated monthly.

Trading Information
19-Oct-17
FTSE index FTSE AIM All-Share,FTSE AIM All-Share - Health Care
FTSE sector Pharmaceuticals & Biotechnology
FTSE sub-sector Biotechnology
Country of share register GB
Segment AIMI
MiFID Status MTF
Exchange market size 3,000
SEDOL 3433067
ISIN number GB0034330679



ANGLE share news analysis (AGL)